Phil Barrington

Phil is a senior pharmaceutical physician and an expert in clinical pharmacology and early development. He has more than 30 years’ industry experience.

Phil qualified in medicine at the University of Southampton, UK.
Phil’s pharmaceutical industry includes clinical pharmacology units, biotech companies and large pharma companies.

He has extensive experience of working with small molecules and biopharmaceutics (monoclonal and bispecific antibodies, fusion proteins, Pegylated peptides and antibody-drug conjugates) and has worked in most therapeutic areas. Phil’s main areas of interest are autoimmune diseases, diabetes, biomarker development and medical devices. He has also worked in rare disease indications such as haemophilia and demyelinating polyneuropathy.

Phil also has broad experience of due diligence activities related to in-licensing and out-licensing as well as the application of PK/PD modelling and simulation to early phase development.

Phil is a current member of the Faculty of Pharmaceutical Medicine’s Board of Examiners.